Kyowa Kirin to Acquire Orchard Therapeutics for US$477.6 M
By Ayush Saxena
Pharma Deals Review: Vol 2023 Issue 10 (Table of Contents)
Published: 14 Oct-2023
DOI: 10.3833/pdr.v2023.i10.2811 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to bolster its rare disease portfolio, Kyowa Kirin has agreed to acquire Orchard Therapeutics for US$16 per American Depositary Share (ADS) in cash, representing a total equity value of US$477...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS